Pregled bibliografske jedinice broj: 536586
Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipaemia
Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipaemia // Physiological research, 63 (2014), 2; 199-205 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 536586 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipaemia
Autori
Turk, Zdenka ; Ljubić, Spomenka ; Boras, Jozo
Izvornik
Physiological research (0862-8408) 63
(2014), 2;
199-205
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
advanced glycation pathway type 2 diabetes macrovascular disease AGE/esRAGE ratio
Sažetak
Endogenous secretory receptor (esRAGE) for advanced glycation end-product (AGE) acts as decoy for AGEs. The AGE-to-esRAGE ratio was hypothesized to be implicated in diabetic vasculopathy. We investigated an association of esRAGE and methylglyoxal-adducts serum level, as well as AGE- to-esRAGE ratio in subpopulation of diabetic patients with or without concomitant hyperlipemia and macrovascular disease in history. In diabetes with concomitant hyperlipemia esRAGE was significantly decreased compared to hyperlipemia with normal glucose metabolism (0.306±0.2 vs. 0.367±0.1 ; p=0.019) or diabetes alone (0.306±0.2 vs. 0.404±0.1 ; p=0.004). High AGE/esRAGE ratio, found in diabetic patients with hyperlipemia, pointed to increased production of AGEs and low expression of esRAGE. In multivariable analysis adjusted for several confounding factors, increased AGE/esRAGE ratio was recognized as a high risk for vascular disease outcomes.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
045-0000000-0165 - GLIKOTOKSINI U ŠEĆERNOJ BOLESTI I KRONIČNIM KOMPLIKACIJAMA (Turk, Zdenka, MZOS ) ( CroRIS)
Ustanove:
Klinička bolnica "Merkur",
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE